1Z64

NMR Solution Structure of Pleurocidin in DPC Micelles

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D NOESY	2mM peptide U-15; 50mM phosphate buffer	90/10 H2O/D2O, 140mM DPC	0mM NaCl	7.0	atmospheric atm	293
2	2D TOCSY	2mM peptide U-15; 50mM phosphate buffer	90/10 H2O/D2O, 140mM DPC	0mM NaCl	7.0	atmospheric atm	293
3	3D_15N-separated_NOESY	2mM peptide U-15; 50mM phosphate buffer	90/10 H2O/D2O, 140mM DPC	0mM NaCl	7.0	atmospheric atm	293
4	DOSY	2mM peptide U-15; 50mM phosphate buffer	90/10 H2O/D2O, 140mM DPC	0mM NaCl	7.0	atmospheric atm	293

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE	500

NMR Refinement
Method	Details	Software
distance geometry; simulated annealing; molecular dynamics		XwinNMR

NMR Ensemble Information
Conformer Selection Criteria	structures with the least restraint violations
Conformers Calculated Total Number	50
Conformers Submitted Total Number	11
Representative Model	1 (closest to the average)

Additional NMR Experimental Information
Details	Structure was determined using 2D and 3D hetronuclear techniques

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	XwinNMR	2.6	Bruker
2	data analysis	Sparky	3.105	Donald Kneller
3	structure solution	X-PLOR	3.1	Brunger
4	refinement	X-PLOR	3.1	Brunger

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.